Article
Genome-wide CRISPRa screens nominate modulators of CAR T cell survival within distinct tumor cytokine milieus
2024-03-17
Abstract excerpt
<h4>ABSTRACT</h4> Chimeric Antigen Receptor (CAR) T cell therapy has revolutionized the treatment of B cell malignancies and translating this success to other cancers remains an ongoing clinical objective. Next-generation T cell products in development aim to genetically modulate many facets of cell behavior, for which gene-nominating platforms provide a useful framework for prioritization. Among competing screen...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 483953fd-eb05-5918-9c59-2c218ccf4f03
- DOI
- 10.1101/2024.03.16.583115
